Anthony S. Basile

Affiliations: 
Allergan LLC 
Area:
Spasticity, Pain
Google:
"Anthony Basile"
Mean distance: 17.71 (cluster 7)
 
SNBCP

Parents

Sign in to add mentor
Phil Skolnick post-doc 1984-1996 NIDDK, NIH

Collaborators

Sign in to add collaborator
Todd D. McIntyre collaborator 1986-1990 NIH (NIDDK)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Warnock KT, Yang AR, Yi HS, et al. (2012) Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology. Pharmacology, Biochemistry, and Behavior. 103: 111-8
Yang AR, Yi HS, Warnock KT, et al. (2012) Effects of the triple monoamine uptake inhibitor DOV 102,677 on alcohol-motivated responding and antidepressant activity in alcohol-preferring (P) rats. Alcoholism, Clinical and Experimental Research. 36: 863-73
FRYER RI, RIOS R, ZHANG P, et al. (2010) ChemInform Abstract: Structure Activity Relationships of 2-Phenylpyrazolo(4,3-c)quinolin-3- ones and Their N- and O-Methyl Analogues at Benzodiazepine Receptors. Cheminform. 25: no-no
Nicholson KL, Balster RL, Golembiowska K, et al. (2009) Preclinical evaluation of the abuse potential of the analgesic bicifadine. The Journal of Pharmacology and Experimental Therapeutics. 330: 236-48
Berezhnoy D, Gravielle MC, Downing S, et al. (2008) Pharmacological Properties of DOV 315,090, an ocinaplon metabolite. Bmc Pharmacology. 8: 11
Tizzano JP, Stribling DS, Perez-Tilve D, et al. (2008) The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity. The Journal of Pharmacology and Experimental Therapeutics. 324: 1111-26
Skolnick P, Basile AS. (2007) Triple reuptake inhibitors ("broad spectrum" antidepressants). Cns & Neurological Disorders Drug Targets. 6: 141-9
Basile AS, Janowsky A, Golembiowska K, et al. (2007) Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. The Journal of Pharmacology and Experimental Therapeutics. 321: 1208-25
Popik P, Kostakis E, Krawczyk M, et al. (2006) The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors. The Journal of Pharmacology and Experimental Therapeutics. 319: 1244-52
Skolnick P, Krieter P, Tizzano J, et al. (2006) Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor. Cns Drug Reviews. 12: 123-34
See more...